As a result, there is substantial interest in small molecules that can directly activate BAK or BAX, as these molecules could potentially induce cancer cell apoptosis directly or sensitize cancer cells to other anti-cancer treatments if suitably targeted to neoplastic cells. The gene discussed is BAX; the disease is cancer.